Prescription Drug Information: VFEND (Page 10 of 10)

PRINCIPAL DISPLAY PANEL — 200 mg Vial Label

NDC 0049-3190-01
Rx ONLY

Vfend® I.V.
(voriconazole) for Injection

Sterile Single-Dose Vial –
Discard Unused Portion

For Intravenous Infusion Only

Not made with natural
rubber latex
No Preservatives

200 mg*
200 mg* of
voriconazole

Distributed by Roerig
Division of Pfizer Inc,
NY, NY 10017
Novaplus is a registeredtrademark of Vizient, Inc.

novaplus

PRINCIPAL DISPLAY PANEL -- 200 mg Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 200 mg Vial Carton

NDC 0049-3190-01

Vfend® I.V.
(voriconazole) for Injection

200 mg*
200 mg* of
voriconazole

1 Vial
Not made with natural rubber latex
No Preservatives
Sterile Single-Dose Vial – Discard Unused Portion

For Intravenous Infusion Only

Rx ONLY

novaplus

PRINCIPAL DISPLAY PANEL -- 200 mg Vial Carton
(click image for full-size original)
VFEND voriconazole injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0049-3190
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VORICONAZOLE (VORICONAZOLE) VORICONAZOLE 10 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
BETADEX SULFOBUTYL ETHER SODIUM
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0049-3190-01 1 VIAL, SINGLE-USE in 1 CARTON contains a VIAL, SINGLE-USE
1 20 mL in 1 VIAL, SINGLE-USE This package is contained within the CARTON (0049-3190-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021267 05/24/2002
Labeler — Roerig (829076996)
Registrant — Pfizer Inc (113480771)
Establishment
Name Address ID/FEI Operations
Pharmacia & Upjohn Company LLC 618054084 ANALYSIS (0049-3190), MANUFACTURE (0049-3190), API MANUFACTURE (0049-3190), PACK (0049-3190), LABEL (0049-3190)
Establishment
Name Address ID/FEI Operations
Pfizer Ireland Pharmaceuticals 985052076 ANALYSIS (0049-3190), API MANUFACTURE (0049-3190)

Revised: 09/2022 Roerig

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.